Covid-19

The scientific community has never gone from genomic sequencing to vaccine approval as fast as it has with Covid-19. Now, health care leaders’ new challenge is to acquire the vaccines and roll out comprehensive vaccination programs that can help us achieve herd immunity. Fortunately, we can learn from past vaccination experiences and current expertise to proactively plan for the biggest likely hurdles to achieving that goal.

FDA has just authorized a coronavirus vaccine created by Pfizer and BioNTech, and tens of millions of doses will begin rolling out within days. We now know enough to answer some of our lingering questions—and to draw conclusions about the effectiveness both of FDA's review process and of the vaccine itself.

Updates on the Covid-19 vaccine candidates are moving fast. In this episode, Rae sits down with Advisory Board's Brandi Greenberg to discuss what we know and don't know about the different Covid-19 vaccine candidates, what challenges health systems may face distributing a vaccine, and how health systems should prepare for the coming Covid-19 vaccine—starting with their own clinicians.

Register for our weekly webinar to get the latest news and insights about Covid-19, vaccine development and distribution, and more of health care's biggest topics.

Our funding source navigation tool centralizes the most relevant information on applicable grants, loans, and reimbursement changes to assist health system CFOs increase liquidity through federal funding amidst the pandemic.